Suppr超能文献

癫痫患者中丙戊酸钠血浆蛋白结合的剂量内变异

Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.

作者信息

Marty J J, Kilpatrick C J, Moulds R F

出版信息

Br J Clin Pharmacol. 1982 Sep;14(3):399-404. doi: 10.1111/j.1365-2125.1982.tb01998.x.

Abstract

1 The fluctuations in protein binding of sodium valproate during one dosing interval were studied in five patients stabilized on valproate and taking concurrent anticonvulsant therapy. 2 The patients took their usual morning dose of valproate (400-800 mg) and serial blood samples were collected by venepuncture at 0, 1, 2, 3, 4, and 6 h post-dose. 3 Free valproate was separated from protein bound drug by plasma ultrafiltration and the ultrafiltrate and total plasma valproate concentrations were measured by a gas chromatographic method. 4 The maximum and minimum concentrations in the ultrafiltrates occurred at the same times as in the plasma. However, the percentage fluctuation was always greater in the ultrafiltrates (range 192-412%) compared with the plasma (range 153-374%) due to the concentration-dependent nature of valproate protein binding. 5 If free valproate levels are to be monitored, knowledge of sampling time and dosage history is important for interpretation of the results.

摘要
  1. 研究了5名服用丙戊酸钠并同时接受抗惊厥治疗的稳定患者在一个给药间隔期内丙戊酸钠蛋白结合的波动情况。

  2. 患者服用其常用的早晨剂量丙戊酸钠(400 - 800毫克),并在给药后0、1、2、3、4和6小时通过静脉穿刺采集系列血样。

  3. 通过血浆超滤将游离丙戊酸与蛋白结合药物分离,并用气相色谱法测定超滤液和总血浆丙戊酸浓度。

  4. 超滤液中的最大和最小浓度与血浆中的出现时间相同。然而,由于丙戊酸蛋白结合的浓度依赖性,超滤液中的波动百分比总是大于血浆中的波动百分比(范围为192 - 412%),而血浆中的波动百分比范围为153 - 374%。

  5. 如果要监测游离丙戊酸水平,了解采样时间和用药史对于结果的解释很重要。

相似文献

7
Plasma concentrations of unbound valproate and the management of epilepsy.
Aust N Z J Med. 1987 Dec;17(6):574-9. doi: 10.1111/j.1445-5994.1987.tb01259.x.
8
Valproic acid dosage and plasma protein binding and clearance.
Clin Pharmacol Ther. 1980 Oct;28(4):486-92. doi: 10.1038/clpt.1980.192.
10
Effect of valproate on free plasma phenytoin concentrations.丙戊酸盐对血浆中游离苯妥英浓度的影响。
Br J Clin Pharmacol. 1984 Jul;18(1):17-20. doi: 10.1111/j.1365-2125.1984.tb05015.x.

本文引用的文献

1
Monitoring of free valproic acid levels?
Ther Drug Monit. 1980;2(2):199-201. doi: 10.1097/00007691-198004000-00015.
2
Therapeutic monitoring of valproic acid.
Ther Drug Monit. 1980;2(1):61-71. doi: 10.1097/00007691-198001000-00008.
6
Valproic acid dosage and plasma protein binding and clearance.
Clin Pharmacol Ther. 1980 Oct;28(4):486-92. doi: 10.1038/clpt.1980.192.
7
Protein binding of valproic acid in uremic patients.
Neurology. 1980 May;30(5):557-9. doi: 10.1212/wnl.30.5.557-a.
8
Clinical pharmacokinetics of valproic acid.丙戊酸的临床药代动力学
Clin Pharmacokinet. 1980 Jan-Feb;5(1):67-83. doi: 10.2165/00003088-198005010-00002.
9
Sodium valproate in treatment of epilepsy.丙戊酸钠治疗癫痫
Br Med J. 1974 Jun 15;2(5919):584-6. doi: 10.1136/bmj.2.5919.584.
10
Valproic acid: reversibly acting drug?丙戊酸:可逆作用药物?
Epilepsia. 1976 Dec;17(4):477-9. doi: 10.1111/j.1528-1157.1976.tb04459.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验